Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Vikram Bhise & Suhayl Dhib-Jalbut. (2016) Further understanding of the immunopathology of multiple sclerosis: impact on future treatments. Expert Review of Clinical Immunology 12:10, pages 1069-1089.
Read now
Read now
Victor M Rivera. (2011) Tovaxin for multiple sclerosis. Expert Opinion on Biological Therapy 11:7, pages 961-967.
Read now
Read now
Mark C. Johnson, Bo Wang & Roland Tisch. (2011) Genetic vaccination for re-establishing T-cell tolerance in type 1 diabetes. Human Vaccines 7:1, pages 27-36.
Read now
Read now
Hideki Garren. (2009) DNA vaccines for autoimmune diseases. Expert Review of Vaccines 8:9, pages 1195-1203.
Read now
Read now
Celio L Silva, Vânia LD Bonato, Rubens R dos Santos-Júnior, Carlos R Zárate-Bladés & Alexandrina Sartori. (2009) Recent advances in DNA vaccines for autoimmune diseases. Expert Review of Vaccines 8:2, pages 239-252.
Read now
Read now
Articles from other publishers (4)
Mohammad Ali Sahraian, Mahsa Owji & Abdorreza Naser Moghadasi. (2016) Concomitant multiple sclerosis and another autoimmune disease: Does the clinical course change?. Clinical Neurology and Neurosurgery 150, pages 92-95.
Crossref
Crossref
Mojtaba Farjam, Guang-Xian Zhang, Bogoljub Ciric & Abdolmohamad Rostami. (2015) Emerging immunopharmacological targets in multiple sclerosis. Journal of the Neurological Sciences 358:1-2, pages 22-30.
Crossref
Crossref
Kewal K. JainKewal K. Jain. 2011. The Handbook of Neuroprotection. The Handbook of Neuroprotection
409
483
.
Kathleen A. Maguire-Zeiss & Howard J. Federoff. (2008) Immune-Directed Gene Therapeutic Development for Alzheimer’s, Prion, and Parkinson’s Diseases. Journal of Neuroimmune Pharmacology 4:3, pages 298-308.
Crossref
Crossref